Stay updated with breaking news from Air Force Material Command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new space art exhibit hosted by the National Museum of the U.S. Air Force in conjunction with the International Association of Astronomical Artists (IAAA) titled “The Beauty of Space,” will open at the museum on Feb. 26, 2021. The Exhibit, which will be,
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to...
National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery News provided by Share this article MONMOUTH JUNCTION, N.J., Feb. 4, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, highlights the recent release from the United Kingdom's internationally renowned National Institute for Health and ...
The two planes will need to be tested and flown before more are built. The U.S. Air Force (USAF) is moving rapidly along with the construction of its first two B-21 Raiders, as the next-generation stealth bomber inches ever closer to full-scale serial production. According to senior Air Force officials, the first B-21 Raider will be completed in early 2022 and undertake its maiden flight later that year. The USAF initially stated that the maiden flight would occur by December 2021, but Randall Walden, director of the Air Force Rapid Capabilities Office, says that this earlier estimate was alw...
Share this article Share this article MONMOUTH JUNCTION, N.J., Jan. 21, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces the immediate appointment of David D. Cox, Ph.D., M.B.A., as Vice President – Global Regulatory Affairs. Dr. Cox was most recently Vice President of Regulatory Affairs for tissue and regenerative technologies at Integra LifeSciences Corporation. He was res...